This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ezhevsky, S. A.
Right arrow Articles by Dowdy, S. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ezhevsky, S. A.
Right arrow Articles by Dowdy, S. F.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, July 2001, p. 4773-4784, Vol. 21, No. 14
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.14.4773-4784.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Differential Regulation of Retinoblastoma Tumor Suppressor Protein by G1 Cyclin-Dependent Kinase Complexes In Vivo

Sergei A. Ezhevsky, Alan Ho, Michelle Becker-Hapak, Penny K. Davis, and Steven F. Dowdy*

Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110

Received 6 April 2001/Accepted 10 April 2001

The retinoblastoma tumor suppressor protein (pRB) negatively regulates early-G1 cell cycle progression, in part, by sequestering E2F transcription factors and repressing E2F-responsive genes. Although pRB is phosphorylated on up to 16 cyclin-dependent kinase (Cdk) sites by multiple G1 cyclin-Cdk complexes, the active form(s) of pRB in vivo remains unknown. pRB is present as an unphosphorylated protein in G0 quiescent cells and becomes hypophosphorylated (~2 mol of PO4 to 1 mol of pRB) in early G1 and hyperphosphorylated (~10 mol of PO4 to 1 mol of pRB) in late G1 phase. Here, we report that hypophosphorylated pRB, present in early G1, represents the biologically active form of pRB in vivo that is assembled with E2Fs and E1A but that both unphosphorylated pRB in G0 and hyperphosphorylated pRB in late G1 fail to become assembled with E2Fs and E1A. Furthermore, using transducible dominant-negative TAT fusion proteins that differentially target cyclin D-Cdk4 or cyclin D-Cdk6 (cyclin D-Cdk4/6) and cyclin E-Cdk2 complexes, namely, TAT-p16 and TAT-dominant-negative Cdk2, respectively, we found that, in vivo, cyclin D-Cdk4/6 complexes hypophosphorylate pRB in early G1 and that cyclin E-Cdk2 complexes inactivate pRB by hyperphosphorylation in late G1. Moreover, we found that cycling human tumor cells expressing deregulated cyclin D-Cdk4/6 complexes, due to deletion of the p16INK4a gene, contained hypophosphorylated pRB that was bound to E2Fs in early G1 and that E2F-responsive genes, including those for dihydrofolate reductase and cyclin E, were transcriptionally repressed. Thus, we conclude that, physiologically, pRB is differentially regulated by G1 cyclin-Cdk complexes.

* Corresponding author. Mailing address: Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110. Phone: (314) 362-1722. Fax: (314) 362-1802. E-mail: dowdy{at}pathology.wustl.edu.

Molecular and Cellular Biology, July 2001, p. 4773-4784, Vol. 21, No. 14
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.14.4773-4784.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Nair, J. S., Ho, A. L., Tse, A. N., Coward, J., Cheema, H., Ambrosini, G., Keen, N., Schwartz, G. K. (2009). Aurora B Kinase Regulates the Postmitotic Endoreduplication Checkpoint via Phosphorylation of the Retinoblastoma Protein at Serine 780. Mol. Biol. Cell 20: 2218-2228 [Abstract] [Full Text]  
  • Gorges, L. L., Lents, N. H., Baldassare, J. J. (2008). The extreme COOH terminus of the retinoblastoma tumor suppressor protein pRb is required for phosphorylation on Thr-373 and activation of E2F. Am. J. Physiol. Cell Physiol. 295: C1151-C1160 [Abstract] [Full Text]  
  • Teachey, D. T., Sheen, C., Hall, J., Ryan, T., Brown, V. I., Fish, J., Reid, G. S. D., Seif, A. E., Norris, R., Chang, Y. J., Carroll, M., Grupp, S. A. (2008). mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia. Blood 112: 2020-2023 [Abstract] [Full Text]  
  • Chen, Y.-J., Shen, M.-R., Chen, Y.-J., Maa, M.-C., Leu, T.-H. (2008). Eps8 decreases chemosensitivity and affects survival of cervical cancer patients. Molecular Cancer Therapeutics 7: 1376-1385 [Abstract] [Full Text]  
  • Driver, K. E., Song, H., Lesueur, F., Ahmed, S., Barbosa-Morais, N. L., Tyrer, J. P., Ponder, B. A.J., Easton, D. F., Pharoah, P. D.P., Dunning, A. M., for the Studies in Epidemiology and Risks of Cance, (2008). Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis 29: 333-341 [Abstract] [Full Text]  
  • Arechiga, A. F., Bell, B. D., Leverrier, S., Weist, B. M., Porter, M., Wu, Z., Kanno, Y., Ramos, S. J., Ong, S. T., Siegel, R., Walsh, C. M. (2007). A Fas-Associated Death Domain Protein/Caspase-8-Signaling Axis Promotes S-Phase Entry and Maintains S6 Kinase Activity in T Cells Responding to IL-2. J. Immunol. 179: 5291-5300 [Abstract] [Full Text]  
  • Denicourt, C., Saenz, C. C., Datnow, B., Cui, X.-S., Dowdy, S. F. (2007). Relocalized p27Kip1 Tumor Suppressor Functions as a Cytoplasmic Metastatic Oncogene in Melanoma. Cancer Res. 67: 9238-9243 [Abstract] [Full Text]  
  • Foijer, F., Delzenne-Goette, E., Dekker, M., te Riele, H. (2007). In vivo Significance of the G2 Restriction Point. Cancer Res. 67: 9244-9247 [Abstract] [Full Text]  
  • Muntean, A. G., Pang, L., Poncz, M., Dowdy, S. F., Blobel, G. A., Crispino, J. D. (2007). Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization. Blood 109: 5199-5207 [Abstract] [Full Text]  
  • Schmitz, N. M.R., Hirt, A., Aebi, M., Leibundgut, K. (2006). Limited Redundancy in Phosphorylation of Retinoblastoma Tumor Suppressor Protein by Cyclin-Dependent Kinases in Acute Lymphoblastic Leukemia. Am. J. Pathol. 169: 1074-1079 [Abstract] [Full Text]  
  • Havens, C. G., Ho, A., Yoshioka, N., Dowdy, S. F. (2006). Regulation of Late G1/S Phase Transition and APCCdh1 by Reactive Oxygen Species. Mol. Cell. Biol. 26: 4701-4711 [Abstract] [Full Text]  
  • Harbour, J. W. (2006). Eye Cancer: Unique Insights into Oncogenesis The Cogan Lecture. IOVS 47: 1737-1745 [Full Text]  
  • Payton, M., Chung, G., Yakowec, P., Wong, A., Powers, D., Xiong, L., Zhang, N., Leal, J., Bush, T. L., Santora, V., Askew, B., Tasker, A., Radinsky, R., Kendall, R., Coats, S. (2006). Discovery and Evaluation of Dual CDK1 and CDK2 Inhibitors.. Cancer Res. 66: 4299-4308 [Abstract] [Full Text]  
  • Seo, D.-W., Li, H., Qu, C.-K., Oh, J., Kim, Y.-S., Diaz, T., Wei, B., Han, J.-W., Stetler-Stevenson, W. G. (2006). Shp-1 Mediates the Antiproliferative Activity of Tissue Inhibitor of Metalloproteinase-2 in Human Microvascular Endothelial Cells. J. Biol. Chem. 281: 3711-3721 [Abstract] [Full Text]  
  • Iuchi, S., Dabelsteen, S., Easley, K., Rheinwald, J. G., Green, H. (2006). Immortalized keratinocyte lines derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 103: 1792-1797 [Abstract] [Full Text]  
  • Boiko, A. D., Porteous, S., Razorenova, O. V., Krivokrysenko, V. I., Williams, B. R., Gudkov, A. V. (2006). A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation. Genes Dev. 20: 236-252 [Abstract] [Full Text]  
  • Takaki, T., Fukasawa, K., Suzuki-Takahashi, I., Semba, K., Kitagawa, M., Taya, Y., Hirai, H. (2005). Preferences for Phosphorylation Sites in the Retinoblastoma Protein of D-Type Cyclin-Dependent Kinases, Cdk4 and Cdk6, In Vitro. J Biochem 137: 381-386 [Abstract] [Full Text]  
  • Trere, D., Ceccarelli, C., Montanaro, L., Tosti, E., Derenzini, M. (2004). Nucleolar Size and Activity Are Related to pRb and p53 Status in Human Breast Cancer. J. Histochem. Cytochem. 52: 1601-1607 [Abstract] [Full Text]  
  • Li, G., Domenico, J., Lucas, J. J., Gelfand, E. W. (2004). Identification of Multiple Cell Cycle Regulatory Functions of p57Kip2 in Human T Lymphocytes. J. Immunol. 173: 2383-2391 [Abstract] [Full Text]  
  • Derenzini, M, Ceccarelli, C, Santini, D, Taffurelli, M, Trere, D (2004). The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status. J. Clin. Pathol. 57: 755-761 [Abstract] [Full Text]  
  • Angus, S. P., Mayhew, C. N., Solomon, D. A., Braden, W. A., Markey, M. P., Okuno, Y., Cardoso, M. C., Gilbert, D. M., Knudsen, E. S. (2004). RB Reversibly Inhibits DNA Replication via Two Temporally Distinct Mechanisms. Mol. Cell. Biol. 24: 5404-5420 [Abstract] [Full Text]  
  • Garnovskaya, M. N., Mukhin, Y. V., Vlasova, T. M., Grewal, J. S., Ullian, M. E., Tholanikunnel, B. G., Raymond, J. R. (2004). Mitogen-induced Rapid Phosphorylation of Serine 795 of the Retinoblastoma Gene Product in Vascular Smooth Muscle Cells Involves ERK Activation. J. Biol. Chem. 279: 24899-24905 [Abstract] [Full Text]  
  • Chen, W., Lee, J., Cho, S. Y., Fine, H. A. (2004). Proteasome-Mediated Destruction of the Cyclin A/Cyclin-Dependent Kinase 2 Complex Suppresses Tumor Cell Growth in Vitro and in Vivo. Cancer Res. 64: 3949-3957 [Abstract] [Full Text]  
  • Kuemmerle, J. F., Zhou, H., Bowers, J. G. (2004). IGF-I stimulates human intestinal smooth muscle cell growth by regulation of G1 phase cell cycle proteins. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G412-G419 [Abstract] [Full Text]  
  • Keenan, S. M., Lents, N. H., Baldassare, J. J. (2004). Expression of Cyclin E Renders Cyclin D-CDK4 Dispensable for Inactivation of the Retinoblastoma Tumor Suppressor Protein, Activation of E2F, and G1-S Phase Progression. J. Biol. Chem. 279: 5387-5396 [Abstract] [Full Text]  
  • Lucas, J. J., Domenico, J., Gelfand, E. W. (2004). Cyclin-Dependent Kinase 6 Inhibits Proliferation of Human Mammary Epithelial Cells. Mol Cancer Res 2: 105-114 [Abstract] [Full Text]  
  • Yu, B. D., Becker-Hapak, M., Snyder, E. L., Vooijs, M., Denicourt, C., Dowdy, S. F. (2003). Distinct and nonoverlapping roles for pRB and cyclin D:cyclin-dependent kinases 4/6 activity in melanocyte survival. Proc. Natl. Acad. Sci. USA 100: 14881-14886 [Abstract] [Full Text]  
  • McKenzie, P. P., Danks, M. K., Kriwacki, R. W., Harris, L. C. (2003). p21Waf1/Cip1 Dysfunction in Neuroblastoma: A Novel Mechanism of Attenuating G0-G1 Cell Cycle Arrest. Cancer Res. 63: 3840-3844 [Abstract] [Full Text]  
  • Guo, C. S., Degnin, C., Fiddler, T. A., Stauffer, D., Thayer, M. J. (2003). Regulation of MyoD Activity and Muscle Cell Differentiation by MDM2, pRb, and Sp1. J. Biol. Chem. 278: 22615-22622 [Abstract] [Full Text]  
  • Ma, Y., Yuan, J., Huang, M., Jove, R., Cress, W. D. (2003). Regulation of the Cyclin D3 Promoter by E2F1. J. Biol. Chem. 278: 16770-16776 [Abstract] [Full Text]  
  • Luvalle, P., Ma, Q., Beier, F. (2003). The Role of Activating Transcription Factor-2 in Skeletal Growth Control. JBJS 85: 133-136 [Full Text]  
  • Lea, N. C., Orr, S. J., Stoeber, K., Williams, G. H., Lam, E. W.-F., Ibrahim, M. A. A., Mufti, G. J., Thomas, N. S. B. (2003). Commitment Point during G0->G1 That Controls Entry into the Cell Cycle. Mol. Cell. Biol. 23: 2351-2361 [Abstract] [Full Text]  
  • Lokuta, M. A., Nuzzi, P. A., Huttenlocher, A. (2003). Calpain regulates neutrophil chemotaxis. Proc. Natl. Acad. Sci. USA 100: 4006-4011 [Abstract] [Full Text]  
  • Denicourt, C., Kozak, C. A., Rassart, E. (2002). Gris1, a New Common Integration Site in Graffi Murine Leukemia Virus-Induced Leukemias: Overexpression of a Truncated Cyclin D2 due to Alternative Splicing. J. Virol. 77: 37-44 [Abstract] [Full Text]  
  • Dimitrova, D. S., Berezney, R. (2002). The spatio-temporal organization of DNA replication sites is identical in primary, immortalized and transformed mammalian cells. J. Cell Sci. 115: 4037-4051 [Abstract] [Full Text]  
  • Feliers, D., Frank, M. A., Riley, D. J. (2002). Activation of Cyclin D1-Cdk4 and Cdk4-Directed Phosphorylation of RB Protein in Diabetic Mesangial Hypertrophy. Diabetes 51: 3290-3299 [Abstract] [Full Text]  
  • Wahab, N. A., Weston, B. S., Roberts, T., Mason, R. M. (2002). Connective Tissue Growth Factor and Regulation of the Mesangial Cell Cycle: Role in Cellular Hypertrophy. J. Am. Soc. Nephrol. 13: 2437-2445 [Abstract] [Full Text]  
  • Hsia, C. Y., Cheng, S., Owyang, A. M., Dowdy, S. F., Liou, H.-C. (2002). c-Rel regulation of the cell cycle in primary mouse B lymphocytes. Int Immunol 14: 905-916 [Abstract] [Full Text]  
  • Hlaing, M., Shen, X., Dazin, P., Bernstein, H. S. (2002). The Hypertrophic Response in C2C12 Myoblasts Recruits the G1 Cell Cycle Machinery. J. Biol. Chem. 277: 23794-23799 [Abstract] [Full Text]  
  • Mirjany, M., Ho, L., Pasinetti, G. M. (2002). Role of Cyclooxygenase-2 in Neuronal Cell Cycle Activity and Glutamate-Mediated Excitotoxicity. J. Pharmacol. Exp. Ther. 301: 494-500 [Abstract] [Full Text]  
  • Fan, G., Ma, X., Kren, B. T., Steer, C. J. (2002). Unbound E2F modulates TGF-{beta}1-induced apoptosis in HuH-7 cells. J. Cell Sci. 115: 3181-3191 [Abstract] [Full Text]  
  • Shibata, Y., Nakamura, T. (2002). Defective Flap Endonuclease 1 Activity in Mammalian Cells Is Associated with Impaired DNA Repair and Prolonged S Phase Delay. J. Biol. Chem. 277: 746-754 [Abstract] [Full Text]  
  • Gutzkow, K. B., Naderi, S., Blomhoff, H. K. (2002). Forskolin-mediated G1 arrest in acute lymphoblastic leukaemia cells: phosphorylated pRB sequesters E2Fs. J. Cell Sci. 115: 1073-1082 [Abstract] [Full Text]  
  • CLEMENT, A., HENRION-CAUDE, A., BESNARD, V., CORROYER, S. (2001). Role of Cyclins in Epithelial Response to Oxidants. Am. J. Respir. Crit. Care Med. 164: S81-84 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»